NeuroPace, Inc.

NASDAQ:NPCE

9.15 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 21.0619.25618.12418.01216.42716.5114.47212.78911.15710.211.37410.99710.33912.6311.21710.75212.7717.649.975
Cost of Revenue 5.645.1224.7814.4674.1944.5384.13.9863.1922.7343.1152.9212.8323.2712.7242.5333.1962.2192.918
Gross Profit 15.4214.13413.34313.54512.23311.97210.3728.8037.9657.4668.2598.0767.5079.3598.4938.2199.5755.4217.057
Gross Profit Ratio 0.7320.7340.7360.7520.7450.7250.7170.6880.7140.7320.7260.7340.7260.7410.7570.7640.750.710.707
Reseach & Development Expenses 5.7546.0655.7845.3774.7955.3435.2635.0895.6115.6695.5775.3454.3294.4374.13.9193.6913.2524.833
General & Administrative Expenses 0000000000000000000
Selling & Marketing Expenses 0000000000000000000
SG&A 13.90914.29915.10413.21913.38814.48313.42813.57312.55312.77112.44411.7469.4219.5278.2677.2817.055.6157.682
Other Expenses 000.0510.2650.1150.122-0.817-0.146-0.103-0.085-0.003-0.264-0.014-2.016-3.0870.205-0.168-1.5341.715
Operating Expenses 19.66320.36420.88818.59618.18319.82618.69118.66218.16418.4418.02117.09113.7513.96412.36711.210.7418.86712.515
Operating Income -4.243-6.23-7.545-5.051-5.95-7.854-8.319-9.859-10.199-10.974-9.762-9.015-6.243-4.605-3.874-2.981-1.166-3.446-5.458
Operating Income Ratio -0.201-0.324-0.416-0.28-0.362-0.476-0.575-0.771-0.914-1.076-0.858-0.82-0.604-0.365-0.345-0.277-0.091-0.451-0.547
Total Other Income Expenses Net 0-1.284-1.38-1.149-1.307-1.27-2.056-1.287-1.586-1.716-1.699-1.678-1.84-3.889-4.936-1.637-2.96-5.347-1.283
Income Before Tax 0-7.514-8.925-6.2-7.257-9.124-10.375-11.146-11.785-12.69-11.461-10.693-8.083-8.494-8.81-4.618-4.126-8.793-6.741
Income Before Tax Ratio 0-0.39-0.492-0.344-0.442-0.553-0.717-0.872-1.056-1.244-1.008-0.972-0.782-0.673-0.785-0.43-0.323-1.151-0.676
Income Tax Expense 000.38-8.5742.3062.2474.0211.2871.5861.7161.699-0.1841.812-0.143-1.2382.0882.6242.2794.713
Net Income 0-7.514-8.925-6.2-7.257-9.124-14.396-12.433-13.371-14.406-13.16-10.693-8.083-8.494-8.81-4.618-4.126-8.793-6.741
Net Income Ratio 0-0.39-0.492-0.344-0.442-0.553-0.995-0.972-1.198-1.412-1.157-0.972-0.782-0.673-0.785-0.43-0.323-1.151-0.676
EPS -0.19-0.26-0.32-0.23-0.28-0.36-0.57-0.5-0.54-0.59-0.54-0.44-0.34-0.48-0.4-0.42-0.37-0.79-0.61
EPS Diluted -0.19-0.26-0.32-0.23-0.28-0.36-0.57-0.5-0.54-0.59-0.54-0.44-0.34-0.48-0.4-0.42-0.37-0.79-0.61
EBITDA -4.243-4.904-6.244-3.555-4.668-6.596-8.015-8.453-9.14-10.094-8.879-8.752-6.157-6.553-6.887-2.664-1.234-4.898-3.661
EBITDA Ratio -0.201-0.255-0.393-0.258-0.284-0.4-0.554-0.72-0.819-0.99-0.781-0.796-0.598-0.519-0.614-0.248-0.098-0.641-0.367